logo

FX.co ★ Elevance Health Inc. Q2 Profit Increases, Beats Estimates

Elevance Health Inc. Q2 Profit Increases, Beats Estimates

Elevance Health Inc. (ELV) reported earnings for its second quarter, showing an increase from the same period last year and surpassing Wall Street projections.

The company reported a net income of $2.3 billion, or $9.85 per share, compared to $1.853 billion, or $7.79 per share, in the same quarter last year.

On an adjusted basis, Elevance Health Inc. posted earnings of $2.362 billion, or $10.12 per share.

Analysts, on average, had anticipated earnings of $10.01 per share, according to Thomson Reuters, with estimates typically excluding special items.

Revenue for the quarter saw a slight decline of 0.4%, dropping to $43.223 billion from $43.377 billion in the prior year.

Here is a summary of Elevance Health Inc.'s (GAAP) second-quarter earnings:

- **Earnings (Q2):** $2.3 billion vs. $1.853 billion last year.

- **EPS (Q2):** $9.85 vs. $7.79 last year.

- **Revenue (Q2):** $43.223 billion vs. $43.377 billion last year.

*Die zur Verfügung gestellte Marktanalyse dient zu den Informationszwecken und sollte als Anforderung zur Eröffnung einer Transaktion nicht ausgelegt werden
Go to the articles list Open trading account